Aimed Bio Inc. (KOSDAQ:0009K0)
56,300
-4,200 (-6.94%)
At close: Mar 19, 2026
Aimed Bio Market Cap
Aimed Bio has a market cap or net worth of 3.58 trillion as of March 20, 2026.
Market Cap
3.58T
Enterprise Value
3.41T
Revenue
29.65B
Ranking
n/a
PE Ratio
n/a
Stock Price
56,300.00
Market Cap Chart
Since December 4, 2025, Aimed Bio's market cap has increased from 2.82T to 3.58T, an increase of 26.69%. That is a compound annual growth rate of 125.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.58T | -3.22% |
| Dec 30, 2025 | 3.70T | 30.91% |
| Dec 4, 2025 | 2.82T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rznomics | 2.59T |
| ROKIT Healthcare | 2.01T |
| Qurient | 1.88T |
| AprilBio | 1.49T |
| JS Link | 1.32T |
| Inventage Lab | 1.11T |
| HansBiomed | 777.24B |
| IntoCell | 741.59B |